LYTIR

Insider · SEC Form 4 · Chief Legal Officer

Christine Ring

Filed with the SEC as Ring Christine; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $2.1M of NRIX. Filed a median of 0 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $2.1M in total.Jun: Insider sales $581KJul: Insider sales $349KAug: Insider sales $382KSep: Insider sales $149KOct: Insider sales $238KNov: Insider sales $432KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $2.1M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. NRIXSold: Nurix Therapeutics, Inc. Nov 3, 2026 6,113 shares filed Nov 4, 2026 4,406 shares held directly after, as filed 10b5-1 plan filing $158K
  2. NRIXSold: Nurix Therapeutics, Inc. Nov 2, 2026 10,602 shares filed Nov 4, 2026 2 transactions 10b5-1 plan filing $274K
  3. NRIXSold: Nurix Therapeutics, Inc. Oct 30, 2026 3,957 shares filed Nov 2, 2026 15,335 shares held directly after, as filed filing $104K
  4. NRIXSold: Nurix Therapeutics, Inc. Oct 2, 2026 5,786 shares filed Oct 2, 2026 9,110 shares held directly after, as filed 10b5-1 plan filing $134K
  5. NRIXSold: Nurix Therapeutics, Inc. Sep 2, 2026 5,787 shares filed Sep 2, 2026 2 transactions 10b5-1 plan filing $149K
  6. NRIXSold: Nurix Therapeutics, Inc. Aug 3, 2026 16,589 shares filed Aug 3, 2026 9,110 shares held directly after, as filed 10b5-1 plan filing $382K
  7. NRIXSold: Nurix Therapeutics, Inc. Jul 30, 2026 3,847 shares filed Jul 30, 2026 19,912 shares held directly after, as filed filing $90K
  8. NRIXSold: Nurix Therapeutics, Inc. Jul 2, 2026 11,008 shares filed Jul 2, 2026 13,579 shares held directly after, as filed 10b5-1 plan filing $259K
  9. NRIXSold: Nurix Therapeutics, Inc. Jun 25, 2026 28,935 shares filed Jun 25, 2026 13,579 shares held directly after, as filed 10b5-1 plan filing $581K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • NRIX: option exercise or conversion (code M), 14 entries, Jun 25 to Nov 2, 2026
Code M
An exercise or conversion of a derivative security received from the company, such as stock options.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.